Cargando…
Etiopathogenesis of ovarian cancer. An inflamm-aging entity?
Ovarian cancer is one of the most common gynecologic cancers and has the highest mortality rate. The risk/protective factors of ovarian cancer suggest that its etiology is multifactorial. Several factors are involved in age-related increases in carcinogenesis, including the accumulation of senescent...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198811/ https://www.ncbi.nlm.nih.gov/pubmed/35719320 http://dx.doi.org/10.1016/j.gore.2022.101018 |
_version_ | 1784727723316346880 |
---|---|
author | Sánchez-Prieto, Manuel Sánchez-Borrego, Rafael Lubián-López, Daniel Maria Pérez-López, Faustino R. |
author_facet | Sánchez-Prieto, Manuel Sánchez-Borrego, Rafael Lubián-López, Daniel Maria Pérez-López, Faustino R. |
author_sort | Sánchez-Prieto, Manuel |
collection | PubMed |
description | Ovarian cancer is one of the most common gynecologic cancers and has the highest mortality rate. The risk/protective factors of ovarian cancer suggest that its etiology is multifactorial. Several factors are involved in age-related increases in carcinogenesis, including the accumulation of senescent cells, inflammaging (a chronic inflammatory state that persists in the elderly), and immunosenescence (aging of the immune system) changes associated with poor immune surveillance. At sites of inflammation, exposure to high levels of inflammatory mediators, such as reactive oxygen species, cytokines, prostaglandins, and growth factors, contributes to increased cell division and genetic and epigenetic changes. These exposure-induced changes promote excessive cell proliferation, increased survival, malignant transformation, and cancer development. Furthermore, the proinflammatory tumor microenvironment contributes to ovarian cancer metastasis and chemoresistance. This narrative review of the literature was carried out to delineate the possible role of inflammaging in the etiopathogenesis of ovarian cancer development. We discuss the current carcinogenic hypotheses, sites of origin, and etiological factors of ovarian cancer. Treatment of inflammation may represent an attractive strategy for both the prevention and therapy of ovarian cancer. |
format | Online Article Text |
id | pubmed-9198811 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-91988112022-06-16 Etiopathogenesis of ovarian cancer. An inflamm-aging entity? Sánchez-Prieto, Manuel Sánchez-Borrego, Rafael Lubián-López, Daniel Maria Pérez-López, Faustino R. Gynecol Oncol Rep Review Article Ovarian cancer is one of the most common gynecologic cancers and has the highest mortality rate. The risk/protective factors of ovarian cancer suggest that its etiology is multifactorial. Several factors are involved in age-related increases in carcinogenesis, including the accumulation of senescent cells, inflammaging (a chronic inflammatory state that persists in the elderly), and immunosenescence (aging of the immune system) changes associated with poor immune surveillance. At sites of inflammation, exposure to high levels of inflammatory mediators, such as reactive oxygen species, cytokines, prostaglandins, and growth factors, contributes to increased cell division and genetic and epigenetic changes. These exposure-induced changes promote excessive cell proliferation, increased survival, malignant transformation, and cancer development. Furthermore, the proinflammatory tumor microenvironment contributes to ovarian cancer metastasis and chemoresistance. This narrative review of the literature was carried out to delineate the possible role of inflammaging in the etiopathogenesis of ovarian cancer development. We discuss the current carcinogenic hypotheses, sites of origin, and etiological factors of ovarian cancer. Treatment of inflammation may represent an attractive strategy for both the prevention and therapy of ovarian cancer. Elsevier 2022-06-11 /pmc/articles/PMC9198811/ /pubmed/35719320 http://dx.doi.org/10.1016/j.gore.2022.101018 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Article Sánchez-Prieto, Manuel Sánchez-Borrego, Rafael Lubián-López, Daniel Maria Pérez-López, Faustino R. Etiopathogenesis of ovarian cancer. An inflamm-aging entity? |
title | Etiopathogenesis of ovarian cancer. An inflamm-aging entity? |
title_full | Etiopathogenesis of ovarian cancer. An inflamm-aging entity? |
title_fullStr | Etiopathogenesis of ovarian cancer. An inflamm-aging entity? |
title_full_unstemmed | Etiopathogenesis of ovarian cancer. An inflamm-aging entity? |
title_short | Etiopathogenesis of ovarian cancer. An inflamm-aging entity? |
title_sort | etiopathogenesis of ovarian cancer. an inflamm-aging entity? |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198811/ https://www.ncbi.nlm.nih.gov/pubmed/35719320 http://dx.doi.org/10.1016/j.gore.2022.101018 |
work_keys_str_mv | AT sanchezprietomanuel etiopathogenesisofovariancanceraninflammagingentity AT sanchezborregorafael etiopathogenesisofovariancanceraninflammagingentity AT lubianlopezdanielmaria etiopathogenesisofovariancanceraninflammagingentity AT perezlopezfaustinor etiopathogenesisofovariancanceraninflammagingentity |